Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

Keyphrases

• Cerebral Vasospasm 100%
• Aneurysmal Subarachnoid Hemorrhage (aSAH) 100%
• Triple-H Therapy 100%
• Randomized Controlled Trial 50%
• Hypertension 50%
• Improved Outcomes 50%
• Mortality Rate 50%
• Morbidity Rate 50%
• Complex Disorders 50%
• Vasospasm 50%
• Hemodilution 50%
• Hypervolemia 50%
• Intensive Care Setting 50%
• Delayed Ischemic Neurological Deficit 50%
• New Thought 50%

Medicine and Dentistry

• Subarachnoid Hemorrhage 100%
• Brain Vasospasm 100%
• Mortality Rate 50%
• Randomized Controlled Trial 50%
• Apoplexy 50%
• Morbidity 50%
• Intensive Care 50%
• Vasospasm 50%
• Hemodilution 50%
• Hypervolemia 50%
• Diseases 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Subarachnoid Hemorrhage 100%
• Brain Vasospasm 100%
• Randomized Controlled Trial 50%
• Cerebrovascular Accident 50%
• Mortality Rate 50%
• Morbidity 50%
• Vasospasm 50%
• Hypervolemia 50%
• Diseases 50%